Creo Medical Current Valuation vs. Shares Outstanding
CREO Stock | 16.00 0.13 0.81% |
For Creo Medical profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Creo Medical to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Creo Medical Group utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Creo Medical's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Creo Medical Group over time as well as its relative position and ranking within its peers.
Creo |
Creo Medical Group Shares Outstanding vs. Current Valuation Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Creo Medical's current stock value. Our valuation model uses many indicators to compare Creo Medical value to that of its competitors to determine the firm's financial worth. Creo Medical Group is the top company in current valuation category among its peers. It also is number one stock in shares outstanding category among its peers creating about 5.86 of Shares Outstanding per Current Valuation. Common Stock Shares Outstanding is likely to gain to about 328.7 M in 2024. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Creo Medical's earnings, one of the primary drivers of an investment's value.Creo Current Valuation vs. Competition
Creo Medical Group is the top company in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is currently estimated at about 131.06 Billion. Creo Medical adds roughly 70.34 Million in current valuation claiming only tiny portion of equities under Health Care industry.
Creo Shares Outstanding vs. Current Valuation
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Creo Medical |
| = | 70.34 M |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Creo Medical |
| = | 412.15 M |
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Creo Shares Outstanding Comparison
Creo Medical is currently under evaluation in shares outstanding category among its peers.
Creo Medical Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Creo Medical, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Creo Medical will eventually generate negative long term returns. The profitability progress is the general direction of Creo Medical's change in net profit over the period of time. It can combine multiple indicators of Creo Medical, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last Reported | Projected for Next Year | ||
Accumulated Other Comprehensive Income | 22.9 M | 24 M | |
Operating Income | -24.8 M | -23.6 M | |
Income Before Tax | -24.5 M | -23.3 M | |
Total Other Income Expense Net | 300 K | 315 K | |
Net Loss | -21.7 M | -20.6 M | |
Income Tax Expense | -2.8 M | -2.9 M | |
Net Loss | -21.7 M | -20.6 M | |
Net Loss | -22.1 M | -21 M | |
Interest Income | 700 K | 735 K | |
Net Interest Income | 300 K | 315 K | |
Change To Netincome | 326.6 K | 286.6 K |
Creo Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Creo Medical. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Creo Medical position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Creo Medical's important profitability drivers and their relationship over time.
Use Creo Medical in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Creo Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Creo Medical will appreciate offsetting losses from the drop in the long position's value.Creo Medical Pair Trading
Creo Medical Group Pair Trading Analysis
The ability to find closely correlated positions to Creo Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Creo Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Creo Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Creo Medical Group to buy it.
The correlation of Creo Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Creo Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Creo Medical Group moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Creo Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Creo Medical position
In addition to having Creo Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Obamacare Thematic Idea Now
Obamacare
Health care services and providers including hospitals, clinics and nursing homes that hope to benefit from Obamacare program. The Obamacare theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Obamacare Theme or any other thematic opportunities.
View All Next | Launch |
Additional Tools for Creo Stock Analysis
When running Creo Medical's price analysis, check to measure Creo Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Creo Medical is operating at the current time. Most of Creo Medical's value examination focuses on studying past and present price action to predict the probability of Creo Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Creo Medical's price. Additionally, you may evaluate how the addition of Creo Medical to your portfolios can decrease your overall portfolio volatility.